Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjuvant Immunotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchUnknownNCT02929797
What this trial is testing

Immunotherapy of CD8+NKG2D+ AKT Cell With Chemotherapy to Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 72
Testing effectiveness (Phase 2)Study completedNCT01909752
What this trial is testing

Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
UbiVac 12
Large-scale testing (Phase 3)Study completedNCT00309530
What this trial is testing

Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C

Who this might be right for
Colon Cancer Stage III
Austrian Breast & Colorectal Cancer Study Group 598
Testing effectiveness (Phase 2)Active Not RecruitingNCT04630730
What this trial is testing

Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC

Who this might be right for
Bladder Cancer
Swiss Cancer Institute 46
Large-scale testing (Phase 3)UnknownNCT03700905
What this trial is testing

Study of Nivolumab Alone or in Combination With Ipilimumab as Immunotherapy vs Standard Follow-up in Surgical Resectable HNSCC After Adjuvant Therapy

Who this might be right for
Head and Neck Cancer
Universitätsklinikum Hamburg-Eppendorf 276
Early research (Phase 1)Study completedNCT04879888
What this trial is testing

Personalized Vaccine for Cancer Immunotherapy

Who this might be right for
Breast Cancer Female
Universidad Nacional de Colombia 9
Testing effectiveness (Phase 2)Looking for participantsNCT06630624
What this trial is testing

Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM

Who this might be right for
Colorectal CancerLiver MetastasesLiver Metastasis Colon Cancer
M.R. Meijerink 120
Large-scale testing (Phase 3)Study completedNCT00033904
What this trial is testing

Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer

Who this might be right for
Renal Cell Carcinoma
Agenus Inc. 650
Testing effectiveness (Phase 2)Active Not RecruitingNCT07658105
What this trial is testing

Eparlitozoviril as Adjuvant Therapy for Resectable HCC With MVI

Who this might be right for
HCC - Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 60
Not applicableLooking for participantsNCT05527795
What this trial is testing

Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma

Who this might be right for
Melanoma
Hospices Civils de Lyon 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT05973864
What this trial is testing

Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery

Who this might be right for
Triple Negative Breast Neoplasms
UNICANCER 220
Testing effectiveness (Phase 2)Looking for participantsNCT06341764
What this trial is testing

Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma

Who this might be right for
Cholangiocarcinoma
National Cancer Institute, Naples 38
Large-scale testing (Phase 3)Looking for participantsNCT03288532
What this trial is testing

Renal Adjuvant MultiPle Arm Randomised Trial

Who this might be right for
Renal Cell Carcinoma
University College, London 1,750
Early research (Phase 1)Study completedNCT03387761
What this trial is testing

Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy

Who this might be right for
Urothelial Carcinoma
The Netherlands Cancer Institute 54
Early research (Phase 1)Looking for participantsNCT06414733
What this trial is testing

HER-2 B Cell Peptide Vaccine

Who this might be right for
Metastatic Breast CancerHER2-positive Breast CancerEGFR Overexpression+2 more
Pravin T.P Kaumaya 42
Not applicableActive Not RecruitingNCT06243679
What this trial is testing

The Efficacy and Safety of Adjuvant Immunotherapy After Pathological Complete Response Following Neoadjuvant Chemoimmunotherapy in Patients with Resectable NSCLC

Who this might be right for
Resectable/Potentially Resectable NSCLC
Xiangya Hospital of Central South University 100
Not applicableNot Yet RecruitingNCT07067450
What this trial is testing

Adjuvant Immunotherapy for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Sichuan University 98
Testing effectiveness (Phase 2)UnknownNCT04848454
What this trial is testing

Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy

Who this might be right for
HER2-negative Breast CancerNeoadjuvant TherapyPathological Complete Response+3 more
Peking University First Hospital 30
Early research (Phase 1)Ended earlyNCT01341496
What this trial is testing

Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal

Who this might be right for
SarcomaMelanomaEpithelial Malignancies+1 more
National Cancer Institute (NCI) 41
Large-scale testing (Phase 3)Active Not RecruitingNCT04564157
What this trial is testing

New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy

Who this might be right for
Non-Small Cell Lung CancerAdjuvant Chemotherapy
Fundación GECP 210
Next Page